The FDA has proposed a new rule that would extend the agencys tobacco authority to cover additional tobacco products.
Products that would be deemed to be subject to FDA regulation are those that meet the statutory definition of a tobacco product, including currently unregulated marketed products, such as electronic cigarettes, cigars, pipe tobacco, nicotine gels, waterpipe (or hookah) tobacco, and dissolvables not already under the FDAs authority. The FDA currently regulates cigarettes, cigarette tobacco, roll-your-own tobacco and smokeless tobacco.
Consistent with currently regulated tobacco products, under the proposed rule, makers of newly deemed tobacco products would, among other requirements, register with the FDA and report product and ingredient listings; market new tobacco products only after FDA review; make direct and implied claims of reduced risk only if the FDA confirms that scientific evidence supports the claim and that marketing the product will benefit public health as a whole; and not distribute free samples.
In addition, under the proposed rule, the following provisions would apply to newly deemed tobacco products: minimum age and identification restrictions to prevent sales to underage youth; requirements to include health warnings; and prohibition of vending machine sales, unless in a facility that never admits youth.
Tobacco remains the leading cause of death and disease in this country, FDA Commissioner Margaret A. Hamburg, MD, said in a news release. This is an important moment for consumer protection and a significant proposal that if finalized as written would bring FDA oversight to many new tobacco products.
Science-based product regulation is a powerful form of consumer protection that can help reduce the public health burden of tobacco use on the American public, including youth.
The FDA proposes different compliance dates for various provisions so that all regulated entities, including small businesses, will have adequate time to comply with the requirements of the proposed rule. Products that are marketed for therapeutic purposes will continue to be regulated as medical products under the FDAs existing drug and device authorities in the Food, Drug & Cosmetic Act.
The proposed rule will be available for public comment for 75 days. While all comments, data, research and other information submitted to the docket will be considered, the FDA specifically seeks comment on whether all cigars should be subject to deeming, and which other provisions of the proposed rule may be appropriate or not appropriate for different kinds of cigars.
The FDA also seeks answers to the many public health questions posed by products, such as e-cigarettes, which do not involve the burning of tobacco and inhalation of its smoke, as the agency develops an appropriate level of regulatory oversight for these products. The FDA seeks comment in this proposed rule as to how such products should be regulated.
Proposed rule: http://1.usa.gov/ROHtaC